Valneva (VALN) said Tuesday that it filed a registration statement with the US Securities and Exchange Commission for the potential sale from time to time of up to $350 million of its ordinary shares, American depositary shares and warrants to buy ordinary shares or ADSs.
The company intends to use the net proceeds to fund manufacturing, commercialization and research and development of its products and product candidates as well as for working capital and general corporate purposes, according to the filing Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.